|DelMar Pharmaceuticals CEO, Jeffrey Bacha discusses new financing & biologic drug research. Speaking in detail about VAL-083. (NASDAQ: DMPI)|
The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.